The Correlation between Glycemic Characteristic and Erythrocyte Indices in Obesity

Dharma Lindarto, Santi Syafril, Dairion Gatot

Abstract


BACKGROUND: Elevated blood glucose level is a major factor in development of diabetic complications due to unfavorable hyperglycemic induced biochemical as well as hematological indices changes. The aim of this study was to evaluate the correlation between glycemic characteristic and erythrocyte indices in obese subjects with different glycemic status.

METHODS: Cross cross-sectional study was designed, and 80 obese subjects were enrolled. The correlations between glycemic characteristic (fasting plasma glucose (FPG), postprandial plasma glucose (PPG), hemoglobin A1c (HbA1c) and homeostasis model assessment of insulin resistance (HOMA-IR)) and erythrocyte indices (Hb, red blood count (RBC), mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH) and mean corpuscular hemoglobin concentration (MCHC)) were evaluated.

RESULTS: Of 80 obese subjects with different glycemic status, there were 48 patients with only obesity (HbA1c <5.7%), 19 patients with pre-diabetes (HbA1c 5.7-6.4%) and 13 patients with diabetes (HbA1c >6.4%). Glycemic characteristic and profile lipid (high-density lipoprotein cholesterol (HDL-C), triglycerides (TG)) were differ significantly in the different HbA1c level. Erythrocyte indices were not differ significantly in the different HbA1c level. Partial Spearman's correlation analysis showed that only MCV was significantly correlated with glycemic characteristic of FPG, PPG, HbA1c and HOMA-IR (r=-0.36, p=0.001; r=-0.29, p=0.007; r=-0.27, p=0.014 and r=-0.236, p=0.035; respectively).

CONCLUSION: MCV was significantly correlated with glycemic characteristic (FPG, PPG, HbA1C and HOMAIR). Further investigations are recommended.

KEYWORDS: MCV, glycemic-characteristic, HbA1c, erythrocyte indices


Full Text:

PDF

References


Cho YI, Mooney MP, Cho DJ. Hemorheological disorders in diabetes mellitus. J Diabetes Sci Technol. 2008; 2: 1130-8, CrossRef.

Stoltz JF, Singh M, Riha P. Hemorheology in Practice. Amsterdam: IOS Press; 1999, NLMID.

Barnes AJ, Locke P, Scudder PR, Dormandy TL, Dormandy JA, Slack J. Is hyperviscosity a treatable component of diabetic microcirculatory disease? Lancet. 1977; 2: 789-91, CrossRef.

Peduzzi M, Melli M, Fonda S, Codeluppi L, Guerrieri F. Comparative evaluation of blood viscosity in diabetic retinopathy. Int Ophthalmol. 1984; 7: 15-9, CrossRef.

Bauersachs RM, Wenby RB, Meiselman HJ. Determination of specific red blood cell aggregation indexes via an automated system. Clin Hemorheol. 1989; 9: 1-25.

Sacks DB, Arnold M, Bakris GL, Bruns DE, Horvath AR, Kirkman MS, et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Diabetes Care. 2011; 34: e61-99, CrossRef.

Gorus F, Mathieu C, Gerlo E. How should HbA1c measurements be reported? Diabetologia. 2006; 49: 7-10, CrossRef.

Selvin E, Steffes MW, Gregg E, Brancati FL, Coresh J. Performance of A1C for the classification and prediction of diabetes. Diabetes Care. 2011; 34: 84-9, CrossRef.

Jabeen F, Rizvi HA, Subhan A. Effect of hyperglycemia on superoxide dismutase defense system and erythrocyte indices in diabetic patients. Pak J Biochem Mol Biol. 2012; 45: 85-9, article.

WHO/IASO/IOTF. The Asia-Pacific Perspective: Redefining Obesity and its Treatment. Melbourne: Health Communications Australia Pty Ltd; 2000, article.

WHO. Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus: Abbreviated Report of a WHO Consultation. Geneva: WHO; 2011, article.

Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28: 412-9, CrossRef.

Hoare EM, Barnes AJ, Dormandy JA. Abnormal blood viscosity in diabetes mellitus and retinopathy. Biorheology. 1976; 13: 21-5, PMID.

Schwartz RS, Madsen JW, Rybicki AC, Nagel RL. Oxidation of spectrin and deformability defects in diabetic erythrocytes. Diabetes. 1991; 40: 701-8, CrossRef.

Singh M, Shin S. Changes in erythrocyte aggregation and deformability in diabetes mellitus: a brief review. Indian J Exp Biol. 2009; 47: 7-15, PMID.

Srour MA, Bilto YY, Juma M, Irhimeh MR. Exposure of human erythrocytes to oxygen radicals causes loss of deformability, increased osmotic fragility, lipid peroxidation and protein degradation. Clin Hemorheol Microcir 2000: 23: 13-21, PMID.

Katiukhin LN. Rheological properties of erythrocytes and lipid profiles of blood plasma. JMED Research 2015; 2015: 1-5, CrossRef.

Jabeen F, Rizvi HA, Aziz F, Wasti AZ. Hyperglycemic induced variations in hematological indices in type 2 diabetics. IJAR. 2013; 1: 322-34, article.

Schulze MB, Rimm EB, Shai I, Rifai N, Hu FB. Relationship between adiponectin and glycemic control, blood lipids, and inflammatory markers in men with type 2 diabetes. Diabetes Care. 2004; 27: 1680-7, CrossRef.




DOI: https://doi.org/10.18585/inabj.v8i3.215

Copyright (c) 2016 The Prodia Education and Research Institute

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

 

Indexed by:

                  

               

                

 

 

The Prodia Education and Research Institute